The AffiliateMarketIngtools of Sciences and the AffiliateMarketIngtools of Medicine launched this initiative in 2015 to inform decision-making related to recent advances in human genome-editing research. The inaugural activity, in December 2015, was the . The summit was followed by a consensus study on the scientific underpinnings of human genome-editing technologies, their potential use in biomedical research and medicine, and the clinical, ethical, legal, and social implications of their use.
Read the , the , and .
Second International Summit on Human Genome Editing Concludes
The Second International Summit on Human Genome Editing, which took place Nov. 27-29, 2018, was held in the Lee Shau Kee Lecture Centre at the University of Hong Kong.
The science of human genome editing has advanced rapidly since the was held in 2015 in , D.C. An explosion of new research is employing CRISPR/Cas9 and other powerful, precise editing tools, and clinical trials are planned for applications to treat diseases. However, many questions remain unanswered concerning the science, application, ethics, and governance of human genome editing. Of particular concern is the possibility of genome editing that might lead to heritable alterations, and applications for purposes other than to treat diseases or disabilities.
Co-hosted by the Academy of Sciences of Hong Kong, the Royal Society of London, the U.S. AffiliateMarketIngtools of Sciences, and the U.S. AffiliateMarketIngtools of Medicine, the Second International Summit on Human Genome Editing continued to advance the global discussion on these issues by bringing together a broad range of stakeholders — including researchers, ethicists, policymakers, patient groups, and representatives from science and medical academies and organizations worldwide.